Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
N/A
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
N/A
General Information
Revision date
2021-01-12
Product name
ZEJULA TABLETS
Product Synonyms
NIRAPARIB TOSYLATE MONOHYDRATE, FORMULATED PRODUCT
Icons in SDS
Company Information
company name
GlaxoSmithKline Canada
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Section 2
Physical hazards
Not classified.
Health hazards
Acute toxicity, oral Category 4 Germ cell mutagenicity Category 1B Reproductive toxicity Category 2 Specific target organ toxicity following Category 2 repeated exposure
Environmental hazards
Hazardous to the aquatic environment, Category 1
Signal word
Danger
Hazard statements
Harmful if swallowed. May cause genetic defects. Suspected of damaging fertility or the unborn child. May cause damage to organs through prolonged or repeated exposure. Very toxic to aquatic life with long lasting effects.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe dust/fume/gas/mist/vapours/spray. Wash hands thoroughly after handling. Do not eat, drink or smoke when using this product. Avoid release to the environment. Wear protective gloves/protective clothing/eye protection/face protection.
Response
Rinse mouth. IF exposed or concerned: Get medical advice/attention. Specific treatment is urgent (see Information on this label). Collect spillage.
Storage
Store locked up.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations.
2.3 Other hazards
Caution - Potent pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
36.265 % of the mixture consists of component(s) of unknown acute oral toxicity. 99.565 % of the mixture consists of component(s) of unknown acute dermal toxicity. 49.285 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
